Top 10 Pharma Inspection Findings from FDA, MHRA, and the Russian Drug Regulator
At the FDA/PharmaLink conference earlier this year, representatives from the Russian State Institute of Drugs and Good Practices (SID&GP), UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and U.S. FDA shared their top ten pharma company inspection findings from FY2019, revealing many similarities and a few differences. [Related: Download the author’s 2020 webinar on this […]